カテゴリー： 世界, 医療/バイオ, LP Information

世界のOTC局所用抗真菌薬市場予測 2023年-2029年

【英語タイトル】Global OTC Topical Antifungals Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00125）・商品コード：LP23DC00125
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のOTC局所用抗真菌薬市場」は、過去の販売実績から2022年の世界のOTC局所用抗真菌薬の総販売量を検討し、2023年から2029年の予測されるOTC局所用抗真菌薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のOTC局所用抗真菌薬の市場規模を掲載し、XXX百万米ドル規模の世界のOTC局所用抗真菌薬市場の詳細な分析を提供します。本インサイトレポートは、世界のOTC局所用抗真菌薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のOTC局所用抗真菌薬市場における各社の独自のポジションをより深く理解するために、OTC局所用抗真菌薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のOTC局所用抗真菌薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。OTC局所用抗真菌薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。OTC局所用抗真菌薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。OTC局所用抗真菌薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

OTC局所用抗真菌薬の世界主要メーカーとしては、Novartis AG、 Merck KGaA、 Dr. Reddy’s Laboratories Ltd.、 Pfizer, Inc.、 Abbott Laboratories、 Bayer AG、 Sanofi、 Crownなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のOTC局所用抗真菌薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではOTC局所用抗真菌薬市場をセグメンテーションし、種類別 (アゾール類、アリルアミン、トルナフテート、ウンデシレン酸、その他)、用途別 (病院薬局、小売薬局、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：アゾール類、アリルアミン、トルナフテート、ウンデシレン酸、その他

・用途別区分：病院薬局、小売薬局、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のOTC局所用抗真菌薬市場の10年間の市場状況・展望は？
・世界および地域別に見たOTC局所用抗真菌薬市場成長の要因は何か？
・OTC局所用抗真菌薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・OTC局所用抗真菌薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：OTC局所用抗真菌薬の年間販売量2018-2029、地域別現状・将来分析
・OTC局所用抗真菌薬の種類別セグメント：アゾール類、アリルアミン、トルナフテート、ウンデシレン酸、その他
・OTC局所用抗真菌薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・OTC局所用抗真菌薬の用途別セグメント：病院薬局、小売薬局、オンライン薬局
・OTC局所用抗真菌薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のOTC局所用抗真菌薬市場
・企業別のグローバルOTC局所用抗真菌薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のOTC局所用抗真菌薬の年間売上：2018-2023年の売上、市場シェア
・企業別のOTC局所用抗真菌薬販売価格
・主要企業のOTC局所用抗真菌薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

OTC局所用抗真菌薬の地域別レビュー
・地域別のOTC局所用抗真菌薬市場規模2018-2023：年間販売量、売上
・主要国別のOTC局所用抗真菌薬市場規模2018-2023：年間販売量、売上
・南北アメリカのOTC局所用抗真菌薬販売の成長
・アジア太平洋のOTC局所用抗真菌薬販売の成長
・ヨーロッパのOTC局所用抗真菌薬販売の成長
・中東・アフリカのOTC局所用抗真菌薬販売の成長

南北アメリカ市場
・南北アメリカの国別のOTC局所用抗真菌薬販売量、売上（2018-2023）
・南北アメリカのOTC局所用抗真菌薬の種類別販売量
・南北アメリカのOTC局所用抗真菌薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のOTC局所用抗真菌薬販売量、売上（2018-2023）
・アジア太平洋のOTC局所用抗真菌薬の種類別販売量
・アジア太平洋のOTC局所用抗真菌薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のOTC局所用抗真菌薬販売量、売上（2018-2023）
・ヨーロッパのOTC局所用抗真菌薬の種類別販売量
・ヨーロッパのOTC局所用抗真菌薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のOTC局所用抗真菌薬販売量、売上（2018-2023）
・中東・アフリカのOTC局所用抗真菌薬の種類別販売量
・中東・アフリカのOTC局所用抗真菌薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・OTC局所用抗真菌薬の製造コスト構造分析
・OTC局所用抗真菌薬の製造プロセス分析
・OTC局所用抗真菌薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・OTC局所用抗真菌薬の主要なグローバル販売業者
・OTC局所用抗真菌薬の主要なグローバル顧客

地域別のOTC局所用抗真菌薬市場予測レビュー
・地域別のOTC局所用抗真菌薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・OTC局所用抗真菌薬の種類別市場規模予測
・OTC局所用抗真菌薬の用途別市場規模予測

主要企業分析
Novartis AG、 Merck KGaA、 Dr. Reddy’s Laboratories Ltd.、 Pfizer, Inc.、 Abbott Laboratories、 Bayer AG、 Sanofi、 Crown
・企業情報
・OTC局所用抗真菌薬製品
・OTC局所用抗真菌薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global OTC Topical Antifungals market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for OTC Topical Antifungals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for OTC Topical Antifungals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for OTC Topical Antifungals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key OTC Topical Antifungals players cover Novartis AG, Merck KGaA, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., Abbott Laboratories, Bayer AG, Sanofi and Crown, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
OTC topical antifungals are over-the-counter medications that are used to treat fungal infections on the skin. This includes creams, lotions, powders, sprays, and other topical formulations that contain antifungal agents.
LPI (LP Information)’ newest research report, the “OTC Topical Antifungals Industry Forecast” looks at past sales and reviews total world OTC Topical Antifungals sales in 2022, providing a comprehensive analysis by region and market sector of projected OTC Topical Antifungals sales for 2023 through 2029. With OTC Topical Antifungals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC Topical Antifungals industry.
This Insight Report provides a comprehensive analysis of the global OTC Topical Antifungals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC Topical Antifungals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC Topical Antifungals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC Topical Antifungals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC Topical Antifungals.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Topical Antifungals market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Azoles

Allylamine

Tolnaftate
Undecylenic Acid
Others
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Novartis AG
Merck KGaA
Dr. Reddy’s Laboratories Ltd.
Pfizer, Inc.
Abbott Laboratories
Bayer AG
Sanofi
Crown
Key Questions Addressed in this Report
What is the 10-year outlook for the global OTC Topical Antifungals market?
What factors are driving OTC Topical Antifungals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do OTC Topical Antifungals market opportunities vary by end market size?
How does OTC Topical Antifungals break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Topical Antifungals Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for OTC Topical Antifungals by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for OTC Topical Antifungals by Country/Region, 2018, 2022 & 2029
2.2 OTC Topical Antifungals Segment by Type
2.2.1 Azoles

2.2.2 Allylamine

2.2.3 Tolnaftate
2.2.4 Undecylenic Acid
2.2.5 Others
2.3 OTC Topical Antifungals Sales by Type
2.3.1 Global OTC Topical Antifungals Sales Market Share by Type (2018-2023)
2.3.2 Global OTC Topical Antifungals Revenue and Market Share by Type (2018-2023)
2.3.3 Global OTC Topical Antifungals Sale Price by Type (2018-2023)
2.4 OTC Topical Antifungals Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 OTC Topical Antifungals Sales by Application
2.5.1 Global OTC Topical Antifungals Sale Market Share by Application (2018-2023)
2.5.2 Global OTC Topical Antifungals Revenue and Market Share by Application (2018-2023)
2.5.3 Global OTC Topical Antifungals Sale Price by Application (2018-2023)
3 Global OTC Topical Antifungals by Company
3.1 Global OTC Topical Antifungals Breakdown Data by Company
3.1.1 Global OTC Topical Antifungals Annual Sales by Company (2018-2023)
3.1.2 Global OTC Topical Antifungals Sales Market Share by Company (2018-2023)
3.2 Global OTC Topical Antifungals Annual Revenue by Company (2018-2023)
3.2.1 Global OTC Topical Antifungals Revenue by Company (2018-2023)
3.2.2 Global OTC Topical Antifungals Revenue Market Share by Company (2018-2023)
3.3 Global OTC Topical Antifungals Sale Price by Company
3.4 Key Manufacturers OTC Topical Antifungals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers OTC Topical Antifungals Product Location Distribution
3.4.2 Players OTC Topical Antifungals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for OTC Topical Antifungals by Geographic Region
4.1 World Historic OTC Topical Antifungals Market Size by Geographic Region (2018-2023)
4.1.1 Global OTC Topical Antifungals Annual Sales by Geographic Region (2018-2023)
4.1.2 Global OTC Topical Antifungals Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic OTC Topical Antifungals Market Size by Country/Region (2018-2023)
4.2.1 Global OTC Topical Antifungals Annual Sales by Country/Region (2018-2023)
4.2.2 Global OTC Topical Antifungals Annual Revenue by Country/Region (2018-2023)
4.3 Americas OTC Topical Antifungals Sales Growth
4.4 APAC OTC Topical Antifungals Sales Growth
4.5 Europe OTC Topical Antifungals Sales Growth
4.6 Middle East & Africa OTC Topical Antifungals Sales Growth
5 Americas
5.1 Americas OTC Topical Antifungals Sales by Country
5.1.1 Americas OTC Topical Antifungals Sales by Country (2018-2023)
5.1.2 Americas OTC Topical Antifungals Revenue by Country (2018-2023)
5.2 Americas OTC Topical Antifungals Sales by Type
5.3 Americas OTC Topical Antifungals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Topical Antifungals Sales by Region
6.1.1 APAC OTC Topical Antifungals Sales by Region (2018-2023)
6.1.2 APAC OTC Topical Antifungals Revenue by Region (2018-2023)
6.2 APAC OTC Topical Antifungals Sales by Type
6.3 APAC OTC Topical Antifungals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe OTC Topical Antifungals by Country
7.1.1 Europe OTC Topical Antifungals Sales by Country (2018-2023)
7.1.2 Europe OTC Topical Antifungals Revenue by Country (2018-2023)
7.2 Europe OTC Topical Antifungals Sales by Type
7.3 Europe OTC Topical Antifungals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Topical Antifungals by Country
8.1.1 Middle East & Africa OTC Topical Antifungals Sales by Country (2018-2023)
8.1.2 Middle East & Africa OTC Topical Antifungals Revenue by Country (2018-2023)
8.2 Middle East & Africa OTC Topical Antifungals Sales by Type
8.3 Middle East & Africa OTC Topical Antifungals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Topical Antifungals
10.3 Manufacturing Process Analysis of OTC Topical Antifungals
10.4 Industry Chain Structure of OTC Topical Antifungals
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 OTC Topical Antifungals Distributors
11.3 OTC Topical Antifungals Customer
12 World Forecast Review for OTC Topical Antifungals by Geographic Region
12.1 Global OTC Topical Antifungals Market Size Forecast by Region
12.1.1 Global OTC Topical Antifungals Forecast by Region (2024-2029)
12.1.2 Global OTC Topical Antifungals Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global OTC Topical Antifungals Forecast by Type
12.7 Global OTC Topical Antifungals Forecast by Application
13 Key Players Analysis
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG OTC Topical Antifungals Product Portfolios and Specifications
13.1.3 Novartis AG OTC Topical Antifungals Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
13.2 Merck KGaA
13.2.1 Merck KGaA Company Information
13.2.2 Merck KGaA OTC Topical Antifungals Product Portfolios and Specifications
13.2.3 Merck KGaA OTC Topical Antifungals Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck KGaA Main Business Overview
13.2.5 Merck KGaA Latest Developments
13.3 Dr. Reddy’s Laboratories Ltd.
13.3.1 Dr. Reddy’s Laboratories Ltd. Company Information
13.3.2 Dr. Reddy’s Laboratories Ltd. OTC Topical Antifungals Product Portfolios and Specifications
13.3.3 Dr. Reddy’s Laboratories Ltd. OTC Topical Antifungals Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Dr. Reddy’s Laboratories Ltd. Main Business Overview
13.3.5 Dr. Reddy’s Laboratories Ltd. Latest Developments
13.4 Pfizer, Inc.
13.4.1 Pfizer, Inc. Company Information
13.4.2 Pfizer, Inc. OTC Topical Antifungals Product Portfolios and Specifications
13.4.3 Pfizer, Inc. OTC Topical Antifungals Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer, Inc. Main Business Overview
13.4.5 Pfizer, Inc. Latest Developments
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Information
13.5.2 Abbott Laboratories OTC Topical Antifungals Product Portfolios and Specifications
13.5.3 Abbott Laboratories OTC Topical Antifungals Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Abbott Laboratories Main Business Overview
13.5.5 Abbott Laboratories Latest Developments
13.6 Bayer AG
13.6.1 Bayer AG Company Information
13.6.2 Bayer AG OTC Topical Antifungals Product Portfolios and Specifications
13.6.3 Bayer AG OTC Topical Antifungals Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bayer AG Main Business Overview
13.6.5 Bayer AG Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi OTC Topical Antifungals Product Portfolios and Specifications
13.7.3 Sanofi OTC Topical Antifungals Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Crown
13.8.1 Crown Company Information
13.8.2 Crown OTC Topical Antifungals Product Portfolios and Specifications
13.8.3 Crown OTC Topical Antifungals Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Crown Main Business Overview
13.8.5 Crown Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. OTC Topical Antifungals Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. OTC Topical Antifungals Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Azoles

Table 4. Major Players of Allylamine

Table 5. Major Players of Tolnaftate
Table 6. Major Players of Undecylenic Acid
Table 7. Major Players of Others
Table 8. Global OTC Topical Antifungals Sales by Type (2018-2023) & (K Units)
Table 9. Global OTC Topical Antifungals Sales Market Share by Type (2018-2023)
Table 10. Global OTC Topical Antifungals Revenue by Type (2018-2023) & ($ million)
Table 11. Global OTC Topical Antifungals Revenue Market Share by Type (2018-2023)
Table 12. Global OTC Topical Antifungals Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global OTC Topical Antifungals Sales by Application (2018-2023) & (K Units)
Table 14. Global OTC Topical Antifungals Sales Market Share by Application (2018-2023)
Table 15. Global OTC Topical Antifungals Revenue by Application (2018-2023)
Table 16. Global OTC Topical Antifungals Revenue Market Share by Application (2018-2023)
Table 17. Global OTC Topical Antifungals Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global OTC Topical Antifungals Sales by Company (2018-2023) & (K Units)
Table 19. Global OTC Topical Antifungals Sales Market Share by Company (2018-2023)
Table 20. Global OTC Topical Antifungals Revenue by Company (2018-2023) ($ Millions)
Table 21. Global OTC Topical Antifungals Revenue Market Share by Company (2018-2023)
Table 22. Global OTC Topical Antifungals Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers OTC Topical Antifungals Producing Area Distribution and Sales Area
Table 24. Players OTC Topical Antifungals Products Offered
Table 25. OTC Topical Antifungals Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global OTC Topical Antifungals Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global OTC Topical Antifungals Sales Market Share Geographic Region (2018-2023)
Table 30. Global OTC Topical Antifungals Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global OTC Topical Antifungals Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global OTC Topical Antifungals Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global OTC Topical Antifungals Sales Market Share by Country/Region (2018-2023)
Table 34. Global OTC Topical Antifungals Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global OTC Topical Antifungals Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas OTC Topical Antifungals Sales by Country (2018-2023) & (K Units)
Table 37. Americas OTC Topical Antifungals Sales Market Share by Country (2018-2023)
Table 38. Americas OTC Topical Antifungals Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas OTC Topical Antifungals Revenue Market Share by Country (2018-2023)
Table 40. Americas OTC Topical Antifungals Sales by Type (2018-2023) & (K Units)
Table 41. Americas OTC Topical Antifungals Sales by Application (2018-2023) & (K Units)
Table 42. APAC OTC Topical Antifungals Sales by Region (2018-2023) & (K Units)
Table 43. APAC OTC Topical Antifungals Sales Market Share by Region (2018-2023)
Table 44. APAC OTC Topical Antifungals Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC OTC Topical Antifungals Revenue Market Share by Region (2018-2023)
Table 46. APAC OTC Topical Antifungals Sales by Type (2018-2023) & (K Units)
Table 47. APAC OTC Topical Antifungals Sales by Application (2018-2023) & (K Units)
Table 48. Europe OTC Topical Antifungals Sales by Country (2018-2023) & (K Units)
Table 49. Europe OTC Topical Antifungals Sales Market Share by Country (2018-2023)
Table 50. Europe OTC Topical Antifungals Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe OTC Topical Antifungals Revenue Market Share by Country (2018-2023)
Table 52. Europe OTC Topical Antifungals Sales by Type (2018-2023) & (K Units)
Table 53. Europe OTC Topical Antifungals Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa OTC Topical Antifungals Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa OTC Topical Antifungals Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa OTC Topical Antifungals Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa OTC Topical Antifungals Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa OTC Topical Antifungals Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa OTC Topical Antifungals Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of OTC Topical Antifungals
Table 61. Key Market Challenges & Risks of OTC Topical Antifungals
Table 62. Key Industry Trends of OTC Topical Antifungals
Table 63. OTC Topical Antifungals Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. OTC Topical Antifungals Distributors List
Table 66. OTC Topical Antifungals Customer List
Table 67. Global OTC Topical Antifungals Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global OTC Topical Antifungals Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas OTC Topical Antifungals Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas OTC Topical Antifungals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC OTC Topical Antifungals Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC OTC Topical Antifungals Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe OTC Topical Antifungals Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe OTC Topical Antifungals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa OTC Topical Antifungals Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa OTC Topical Antifungals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global OTC Topical Antifungals Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global OTC Topical Antifungals Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global OTC Topical Antifungals Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global OTC Topical Antifungals Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Novartis AG Basic Information, OTC Topical Antifungals Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis AG OTC Topical Antifungals Product Portfolios and Specifications
Table 83. Novartis AG OTC Topical Antifungals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Novartis AG Main Business
Table 85. Novartis AG Latest Developments
Table 86. Merck KGaA Basic Information, OTC Topical Antifungals Manufacturing Base, Sales Area and Its Competitors
Table 87. Merck KGaA OTC Topical Antifungals Product Portfolios and Specifications
Table 88. Merck KGaA OTC Topical Antifungals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Merck KGaA Main Business
Table 90. Merck KGaA Latest Developments
Table 91. Dr. Reddy’s Laboratories Ltd. Basic Information, OTC Topical Antifungals Manufacturing Base, Sales Area and Its Competitors
Table 92. Dr. Reddy’s Laboratories Ltd. OTC Topical Antifungals Product Portfolios and Specifications
Table 93. Dr. Reddy’s Laboratories Ltd. OTC Topical Antifungals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Dr. Reddy’s Laboratories Ltd. Main Business
Table 95. Dr. Reddy’s Laboratories Ltd. Latest Developments
Table 96. Pfizer, Inc. Basic Information, OTC Topical Antifungals Manufacturing Base, Sales Area and Its Competitors
Table 97. Pfizer, Inc. OTC Topical Antifungals Product Portfolios and Specifications
Table 98. Pfizer, Inc. OTC Topical Antifungals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Pfizer, Inc. Main Business
Table 100. Pfizer, Inc. Latest Developments
Table 101. Abbott Laboratories Basic Information, OTC Topical Antifungals Manufacturing Base, Sales Area and Its Competitors
Table 102. Abbott Laboratories OTC Topical Antifungals Product Portfolios and Specifications
Table 103. Abbott Laboratories OTC Topical Antifungals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Abbott Laboratories Main Business
Table 105. Abbott Laboratories Latest Developments
Table 106. Bayer AG Basic Information, OTC Topical Antifungals Manufacturing Base, Sales Area and Its Competitors
Table 107. Bayer AG OTC Topical Antifungals Product Portfolios and Specifications
Table 108. Bayer AG OTC Topical Antifungals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Bayer AG Main Business
Table 110. Bayer AG Latest Developments
Table 111. Sanofi Basic Information, OTC Topical Antifungals Manufacturing Base, Sales Area and Its Competitors
Table 112. Sanofi OTC Topical Antifungals Product Portfolios and Specifications
Table 113. Sanofi OTC Topical Antifungals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Sanofi Main Business
Table 115. Sanofi Latest Developments
Table 116. Crown Basic Information, OTC Topical Antifungals Manufacturing Base, Sales Area and Its Competitors
Table 117. Crown OTC Topical Antifungals Product Portfolios and Specifications
Table 118. Crown OTC Topical Antifungals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Crown Main Business
Table 120. Crown Latest Developments
List of Figures
Figure 1. Picture of OTC Topical Antifungals
Figure 2. OTC Topical Antifungals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Topical Antifungals Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global OTC Topical Antifungals Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. OTC Topical Antifungals Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Azoles

Figure 10. Product Picture of Allylamine

Figure 11. Product Picture of Tolnaftate
Figure 12. Product Picture of Undecylenic Acid
Figure 13. Product Picture of Others
Figure 14. Global OTC Topical Antifungals Sales Market Share by Type in 2022
Figure 15. Global OTC Topical Antifungals Revenue Market Share by Type (2018-2023)
Figure 16. OTC Topical Antifungals Consumed in Hospital Pharmacies
Figure 17. Global OTC Topical Antifungals Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 18. OTC Topical Antifungals Consumed in Retail Pharmacies
Figure 19. Global OTC Topical Antifungals Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 20. OTC Topical Antifungals Consumed in Online Pharmacies
Figure 21. Global OTC Topical Antifungals Market: Online Pharmacies (2018-2023) & (K Units)
Figure 22. Global OTC Topical Antifungals Sales Market Share by Application (2022)
Figure 23. Global OTC Topical Antifungals Revenue Market Share by Application in 2022
Figure 24. OTC Topical Antifungals Sales Market by Company in 2022 (K Units)
Figure 25. Global OTC Topical Antifungals Sales Market Share by Company in 2022
Figure 26. OTC Topical Antifungals Revenue Market by Company in 2022 ($ Million)
Figure 27. Global OTC Topical Antifungals Revenue Market Share by Company in 2022
Figure 28. Global OTC Topical Antifungals Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global OTC Topical Antifungals Revenue Market Share by Geographic Region in 2022
Figure 30. Americas OTC Topical Antifungals Sales 2018-2023 (K Units)
Figure 31. Americas OTC Topical Antifungals Revenue 2018-2023 ($ Millions)
Figure 32. APAC OTC Topical Antifungals Sales 2018-2023 (K Units)
Figure 33. APAC OTC Topical Antifungals Revenue 2018-2023 ($ Millions)
Figure 34. Europe OTC Topical Antifungals Sales 2018-2023 (K Units)
Figure 35. Europe OTC Topical Antifungals Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa OTC Topical Antifungals Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa OTC Topical Antifungals Revenue 2018-2023 ($ Millions)
Figure 38. Americas OTC Topical Antifungals Sales Market Share by Country in 2022
Figure 39. Americas OTC Topical Antifungals Revenue Market Share by Country in 2022
Figure 40. Americas OTC Topical Antifungals Sales Market Share by Type (2018-2023)
Figure 41. Americas OTC Topical Antifungals Sales Market Share by Application (2018-2023)
Figure 42. United States OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC OTC Topical Antifungals Sales Market Share by Region in 2022
Figure 47. APAC OTC Topical Antifungals Revenue Market Share by Regions in 2022
Figure 48. APAC OTC Topical Antifungals Sales Market Share by Type (2018-2023)
Figure 49. APAC OTC Topical Antifungals Sales Market Share by Application (2018-2023)
Figure 50. China OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 54. India OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe OTC Topical Antifungals Sales Market Share by Country in 2022
Figure 58. Europe OTC Topical Antifungals Revenue Market Share by Country in 2022
Figure 59. Europe OTC Topical Antifungals Sales Market Share by Type (2018-2023)
Figure 60. Europe OTC Topical Antifungals Sales Market Share by Application (2018-2023)
Figure 61. Germany OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 62. France OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa OTC Topical Antifungals Sales Market Share by Country in 2022
Figure 67. Middle East & Africa OTC Topical Antifungals Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa OTC Topical Antifungals Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa OTC Topical Antifungals Sales Market Share by Application (2018-2023)
Figure 70. Egypt OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country OTC Topical Antifungals Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of OTC Topical Antifungals in 2022
Figure 76. Manufacturing Process Analysis of OTC Topical Antifungals
Figure 77. Industry Chain Structure of OTC Topical Antifungals
Figure 78. Channels of Distribution
Figure 79. Global OTC Topical Antifungals Sales Market Forecast by Region (2024-2029)
Figure 80. Global OTC Topical Antifungals Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global OTC Topical Antifungals Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global OTC Topical Antifungals Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global OTC Topical Antifungals Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global OTC Topical Antifungals Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のOTC局所用抗真菌薬市場予測 2023年-2029年] (コード：LP23DC00125)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のOTC局所用抗真菌薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の局所トロンビン市場予測 2023年-2029年
  • 世界のOTC局所用かゆみ止め市場予測 2023年-2029年
  • 世界の局所生体接着剤市場予測 2023年-2029年
  • 世界の医薬品用プレリキサフォル市場予測 2023年-2029年
  • 世界の医薬品用デクスランソプラゾール市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆